Applied Clinical Trials
Outlining the ways FDA is adopting electronic practices and initiating efforts to simplify the submission process for new drug and generic drug applications.
Mary Ann Slack
Advertisement
Mary Ann Slack is Deputy Director, Office of Strategic Programs, Center for Drug Evaluation and Research (CDER), Food & Drug Administration.
Articles by Mary Ann Slack
Advertisement
Latest Updated Articles
Leveraging Health IT to Improve Drug DevelopmentAugust 1st 2017
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
The Role of Clinical Research Professionals: From Early Discovery to Phase III Success
2
Continuous Glucose Monitoring in Diabetes Clinical Trials: Endpoints, Regulatory Guidance, and Operational Best Practices
3
What Smaller Biotechs Need to Get Right in Their First APAC Phase III Trial
4
AI Can Draft the CSR Faster, But Does That Make Drug Development Faster?
5